416 related articles for article (PubMed ID: 18058309)
1. In vitro approaches to the identification and characterization of skin sensitizers.
Basketter D; Maxwell G
Cutan Ocul Toxicol; 2007; 26(4):359-73. PubMed ID: 18058309
[TBL] [Abstract][Full Text] [Related]
2. Skin sensitization: strategies for the assessment and management of risk.
Basketter DA
Br J Dermatol; 2008 Aug; 159(2):267-73. PubMed ID: 18503602
[TBL] [Abstract][Full Text] [Related]
3. Novel approach for classifying chemicals according to skin sensitizing potency by non-radioisotopic modification of the local lymph node assay.
Takeyoshi M; Iida K; Shiraishi K; Hoshuyama S
J Appl Toxicol; 2005; 25(2):129-34. PubMed ID: 15744759
[TBL] [Abstract][Full Text] [Related]
4. Quantitative relationship between the local lymph node assay and human skin sensitization assays.
Schneider K; Akkan Z
Regul Toxicol Pharmacol; 2004 Jun; 39(3):245-55. PubMed ID: 15135206
[TBL] [Abstract][Full Text] [Related]
5. Skin sensitization potency of methyl methacrylate in the local lymph node assay: comparisons with guinea-pig data and human experience.
Betts CJ; Dearman RJ; Heylings JR; Kimber I; Basketter DA
Contact Dermatitis; 2006 Sep; 55(3):140-7. PubMed ID: 16918612
[TBL] [Abstract][Full Text] [Related]
6. Predictive identification of human skin sensitization thresholds.
Basketter DA; Clapp C; Jefferies D; Safford B; Ryan CA; Gerberick F; Dearman RJ; Kimber I
Contact Dermatitis; 2005 Nov; 53(5):260-7. PubMed ID: 16283904
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the skin sensitization potency of eugenol and its dimers using a non-radioisotopic modification of the local lymph node assay.
Takeyoshi M; Noda S; Yamazaki S; Kakishima H; Yamasaki K; Kimber I
J Appl Toxicol; 2004; 24(1):77-81. PubMed ID: 14745850
[TBL] [Abstract][Full Text] [Related]
8. Contact allergenic potency: correlation of human and local lymph node assay data.
Gerberick GF; Robinson MK; Ryan CA; Dearman RJ; Kimber I; Basketter DA; Wright Z; Marks JG
Am J Contact Dermat; 2001 Sep; 12(3):156-61. PubMed ID: 11526521
[TBL] [Abstract][Full Text] [Related]
9. Local lymph node assay (LLNA) for detection of sensitization capacity of chemicals.
Gerberick GF; Ryan CA; Dearman RJ; Kimber I
Methods; 2007 Jan; 41(1):54-60. PubMed ID: 16938465
[TBL] [Abstract][Full Text] [Related]
10. Interactions of contact allergens with dendritic cells: opportunities and challenges for the development of novel approaches to hazard assessment.
Ryan CA; Gerberick GF; Gildea LA; Hulette BC; Betts CJ; Cumberbatch M; Dearman RJ; Kimber I
Toxicol Sci; 2005 Nov; 88(1):4-11. PubMed ID: 16014741
[TBL] [Abstract][Full Text] [Related]
11. Skin irritation and sensitization: mechanisms and new approaches for risk assessment.
Basketter D; Darlenski R; Fluhr JW
Skin Pharmacol Physiol; 2008; 21(4):191-202. PubMed ID: 18509253
[TBL] [Abstract][Full Text] [Related]
12. The impact of vehicle on the relative potency of skin-sensitizing chemicals in the local lymph node assay.
Jowsey IR; Clapp CJ; Safford B; Gibbons BT; Basketter DA
Cutan Ocul Toxicol; 2008; 27(2):67-75. PubMed ID: 18568891
[TBL] [Abstract][Full Text] [Related]
13. The local lymph node assay and the assessment of relative potency: status of validation.
Basketter DA; Gerberick F; Kimber I
Contact Dermatitis; 2007 Aug; 57(2):70-5. PubMed ID: 17627643
[TBL] [Abstract][Full Text] [Related]
14. A future approach to measuring relative skin sensitising potency: a proposal.
Jowsey IR; Basketter DA; Westmoreland C; Kimber I
J Appl Toxicol; 2006; 26(4):341-50. PubMed ID: 16773645
[TBL] [Abstract][Full Text] [Related]
15. Development of a peptide reactivity assay for screening contact allergens.
Gerberick GF; Vassallo JD; Bailey RE; Chaney JG; Morrall SW; Lepoittevin JP
Toxicol Sci; 2004 Oct; 81(2):332-43. PubMed ID: 15254333
[TBL] [Abstract][Full Text] [Related]
16. Non-enzymatic glutathione reactivity and in vitro toxicity: a non-animal approach to skin sensitization.
Aptula AO; Patlewicz G; Roberts DW; Schultz TW
Toxicol In Vitro; 2006 Mar; 20(2):239-47. PubMed ID: 16112535
[TBL] [Abstract][Full Text] [Related]
17. The local lymph node assay and skin sensitization testing.
Kimber I; Dearman RJ
Methods Mol Biol; 2010; 598():221-31. PubMed ID: 19967517
[TBL] [Abstract][Full Text] [Related]
18. A chemical dataset for evaluation of alternative approaches to skin-sensitization testing.
Gerberick GF; Ryan CA; Kern PS; Dearman RJ; Kimber I; Patlewicz GY; Basketter DA
Contact Dermatitis; 2004 May; 50(5):274-88. PubMed ID: 15209809
[TBL] [Abstract][Full Text] [Related]
19. A quantitative approach to assess the potency of skin sensitizers in the elicitation phase.
Ezendam J; Vermeulen JP; de Klerk A; de Jong WH; van Loveren H
Toxicology; 2012 Sep; 299(1):20-4. PubMed ID: 22564262
[TBL] [Abstract][Full Text] [Related]
20. Assessment of chemical skin-sensitizing potency by an in vitro assay based on human dendritic cells.
Lambrechts N; Vanheel H; Nelissen I; Witters H; Van Den Heuvel R; Van Tendeloo V; Schoeters G; Hooyberghs J
Toxicol Sci; 2010 Jul; 116(1):122-9. PubMed ID: 20375081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
